Nitrobenzoxadiazole-based GSTP1-1 inhibitors containing the full peptidyl moiety of (pseudo)glutathione

References

• Wu B, Dong D. Human cytosolic glutathione transferases: structure, function, and drug discovery. Trends Pharmacol Sci 2012;33:656–68
   PubMed Web of Science ®Google Scholar
• Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005;45:51–88
   PubMed Web of Science ®Google Scholar
• Salinas AE, Wong MG. Glutathione S-transferases – a review. Curr Med Chem 1999;6:279–309
   PubMed Web of Science ®Google Scholar
• Tew KD, Townsend DM. Glutathione-S-transferases as determinants of cell survival and death. Antioxid Redox Signal 2012;17:1728–37
   PubMed Web of Science ®Google Scholar
• Armstrong RN. Structure, catalytic mechanism, and evolution of the glutathione transferases. Chem Res Toxicol 1997;10:2–18
   PubMed Web of Science ®Google Scholar
• Tew KD. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res 1994;54:4313–20
   PubMed Web of Science ®Google Scholar
• Adler V, Yin Z, Fuchs SY, et al. Regulation of JNK signaling by GSTp. EMBO J 1999;18:1321–34
   PubMed Web of Science ®Google Scholar
• Wu Y, Fan Y, Xue B, et al. Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2-ASK1 signals. Oncogene 2006;25:5787–800
   PubMed Web of Science ®Google Scholar
• Singh S. Cytoprotective and regulatory functions of glutathione S-transferases in cancer cell proliferation and cell death. Cancer Chemother Pharmacol 2015;75:1–15
   PubMed Web of Science ®Google Scholar
• Lyttle MH, Hocker MD, Hui HC, et al. Isozyme-specific glutathione-S-transferase inhibitors: design and synthesis. J Med Chem 1994;37:189–94
   PubMed Web of Science ®Google Scholar
• Klotz P, Slaoui-Hasnaoui A, Banères JL, et al. Synthesis and glutathione S-transferase structure–affinity relationships of nonpeptide and peptidase-stable glutathione analogues. J Med Chem 1998;41:2278–88
   PubMed Web of Science ®Google Scholar
• Musdal Y, Hegazy UM, Aksoy Y, Mannervik B. FDA-approved drugs and other compounds tested as inhibitors of human glutathione transferase P1-1. Chem Biol Interact 2013;205:53–62
   PubMed Web of Science ®Google Scholar
• Ricci G, De Maria F, Antonini G, et al. 7-Nitro-2,1,3-benzoxadiazole derivatives, a new class of suicide inhibitors for glutathione S-transferases. Mechanism of action of potential anticancer drugs. J Biol Chem 2005;280:26397–405
   PubMed Web of Science ®Google Scholar
• Turella P, Cerella C, Filomeni G, et al. Proapoptotic activity of new glutathione S-transferase inhibitors. Cancer Res 2005;65:3751–61
   PubMed Web of Science ®Google Scholar
• De Luca A, Federici L, De Canio M, et al. New insights into the mechanism of JNK1 inhibition by glutathione transferase P1-1. Biochemistry 2012;51:7304–12
   PubMed Web of Science ®Google Scholar
• De Luca A, Mei G, Rosato N, et al. The fine-tuning of TRAF2-GSTP1-1 interaction: effect of ligand binding and in situ detection of the complex. Cell Death Dis 2014;5:e1015
   PubMed Web of Science ®Google Scholar
• Rotili D, De Luca A, Tarantino D, et al. Synthesis and structure–activity relationship of new cytotoxic agents targeting human glutathione-S-transferases. Eur J Med Chem 2015;89:156–71
   PubMed Web of Science ®Google Scholar
• Burg D, Mulder GJ. Glutathione conjugates and their synthetic derivatives as inhibitors of glutathione-dependent enzymes involved in cancer and drug resistance. Drug Metab Rev 2002;34:821–63
   PubMed Web of Science ®Google Scholar
• Meyer DJ. Significance of an unusually low Km for glutathione in glutathione transferases of the alpha, mu and pi classes. Xenobiotica 1993;23:823–34
   PubMed Web of Science ®Google Scholar
• Oakley AJ, Lo Bello M, Mazzetti AP, et al. The glutathione conjugate of ethacrynic acid can bind to human pi class glutathione transferase P1-1 in two different modes. FEBS Lett 1997;419:32–6
   PubMed Web of Science ®Google Scholar
• Borst P, Evers R, Kool M, Wijnholds J. A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst 2000;92:1295–302
   PubMed Web of Science ®Google Scholar
• Keppler D. Export pumps for glutathione S-conjugates. Free Radic Biol Med 1999;27:985–91
   PubMed Web of Science ®Google Scholar
• Bellamy WT, Dalton WS. Multidrug resistance in the laboratory and clinic. Adv Clin Chem 1994;31:1–61
   PubMed Web of Science ®Google Scholar
• Mahjoubi F, Golalipour M, Ghavamzadeh A, Alimoghaddam K. Expression of MRP1 gene in acute leukemia. Sao Paulo Med J 2008;126:172–9
   PubMed Web of Science ®Google Scholar
• Johansson A-S, Ridderström M, Mannervik B. The human glutathione transferase P1-1 specific inhibitor TER 117 designed for overcoming cytostatic-drug resistance is also a strong inhibitor of glyoxalase I. Mol Pharm 2000;57:619–24
   Web of Science ®Google Scholar
• O'Brien ML, Vulevic B, Freer S, et al. Glutathione peptidomimetic drug modulator of multidrug resistance-associated protein. J Pharmacol Exp Ther 1999;291:1348–55
   PubMed Web of Science ®Google Scholar
• Luisi G, Calcagni A, Pinnen F. ψ(SO2NH) transition state isosteres of peptides. Synthesis of the glutathione disulfide analogue (Glu-ψ(SO2NH)-Cys-Gly)2. Tetrahedron Lett 1993;34:2391–2
   Web of Science ®Google Scholar
• Calcagni A, Duprè S, Lucente G, et al. Synthesis and activity of the glutathione analogue γ-(l-γ-azaglutamyl)-l-cisteinyl-glycine. Int J Peptide Protein Res 1995;46:434–9
   PubMedGoogle Scholar
• Calcagni A, Duprè S, Lucente G, et al. Synthesis and activity of the glutathione analogue γ-(l-γ-oxaglutamyl)-l-cysteinyl-glycine. Arch Pharm Pharm Med Chem 1996;329:498–502
   PubMed Web of Science ®Google Scholar
• Cacciatore I, Di Stefano A, Luisi G, et al. Transition state isosteres of the γ-glutamyl peptide bond hydrolysis: synthesis and characterization of the ψ(CH2NH) pseudopeptide analogue of glutathione. J Peptide Sci 2004;10:109–14
   PubMed Web of Science ®Google Scholar
• Cacciatore I, Caccuri AM, Di Stefano A, et al. Synthesis and activity of novel glutathione analogues containing an urethane backbone linkage. Il Farmaco 2003;58:787–93
   PubMedGoogle Scholar
• Cacciatore I, Caccuri AM, Cocco A, et al. Potent isozyme-selective inhibition of human glutathione S-transferase A1-1 by a novel glutathione S-conjugate. Amino Acids 2005;29:255–61
   PubMed Web of Science ®Google Scholar
• Paradisi MP, Mollica A, Cacciatore I, et al. Proline-glutamate chimeras in isopeptides. Synthesis and biological evaluation of conformationally restricted glutathione analogues. Bioorg Med Chem 2003;11:1677–83
   PubMed Web of Science ®Google Scholar
• Calcagni A, Lucente G, Luisi G, et al. Novel glutathione analogues containing the dithiol and disulfide form of the Cys–Cys dyad. Amino Acids 1999;17:257–65
   PubMed Web of Science ®Google Scholar
• Burg D, Filippov DV, Hermanns R, et al. Peptidomimetic glutathione analogues as novel γGT stable GST inhibitors. Bioorg Med Chem 2002;10:195–205
   PubMed Web of Science ®Google Scholar
• Burg D, Wielinga P, Zelcer N, et al. Inhibition of the multidrug resistance protein 1 (MRP1) by peptidomimetic glutathione-conjugate analogs. Mol Pharmacol 2002;62:1160–6
   PubMed Web of Science ®Google Scholar
• Birkett DJ, Price NC, Radda GK, Salmon AG. The reactivity of SH groups with a fluorogenic reagent. FEBS Lett 1970;6:346–8
   PubMed Web of Science ®Google Scholar
• Lo Bello M, Battistoni A, Mazzetti AP, et al. Site-directed mutagenesis of human glutathione transferase P1-1. Spectral, kinetic, and structural properties of Cys-47 and Lys-54 mutants. J Biol Chem 1995;270:1249–53
   PubMed Web of Science ®Google Scholar
• Habig WH, Jakoby WB. Assay for differentiation of glutathione S-transferase. Methods Enzymol 1981;77:237–53
   PubMedGoogle Scholar
• Ploemen JHTM, van Ommen B, van Bladeren PJ. Inhibition of rat and human glutathione S-transferase isoenzymes by ethacrynic acid and its glutathione conjugate. Biochem Pharmacol 1990;40:1631–5
   PubMed Web of Science ®Google Scholar
• Baines BS, Allen G, Brocklehurst K. The highly electrophilic character of 4-chloro-7-nitrobenzofurazan and possible consequences for its applications as a protein-labelling reagent. Biochem J 1977;163:189–92
   PubMed Web of Science ®Google Scholar